Herpes Zoster Subunit Vaccine Shows Great Efficacy in Adults 70 and Older

Herpes Zoster Subunit Vaccine Shows Great Efficacy in Adults 70 and Older

Great news in the world of vaccines! In the ZOE-70 Study, the herpes zoster subunit vaccine (HZ/su) was showed to decrease the risk of herpes zoster by 89.8% in adults 70 years of age and older.

Herpes zoster, or shingles, results from the reactivation of latent varicella–zoster virus (VZV) and is recognized as a painful rash on the skin (postherpetic neuralgia). It also affects nerve fibers , causing burning pain that lasts long after the rash and blisters of shingles disappear.

See the video below to learn more about this study and some of the exciting results!

To read more about this trial click here

 

Submit a Comment

Your email address will not be published. Required fields are marked *